Sep 30, 2015

United Therapeutics Q3 2015 Earnings Report

Total Revenue
$386M
Previous year: $330M
+17.0%
EPS
$3.55
Previous year: $3.91
-9.2%
Gross Profit
$379M
Previous year: $289M
+31.2%
Cash and Equivalents
$765M
Previous year: $497M
+53.9%
Total Assets
$2.16B
Previous year: $2.07B
+4.2%

United Therapeutics

United Therapeutics